5 active warrant series; nearest expiry 2028-11-26.
Compare this book against every issuer →5 option grants covering 2,300,000 shares (~3.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.41 | Nov 26, 2028 790d | 1.2M | OTM | 1.9% | C$492K | Auto |
| option | $0.65 | Dec 30, 2028 824d | 750K | OTM | 1.2% | C$488K | Auto |
| option | $0.31 | Mar 24, 2029 908d | 250K | OTM | 0.4% | C$78K | Auto |
| option | $0.41 | Nov 26, 2030 1520d | 60K | OTM | 0.1% | C$25K | Auto |
| option | $0.65 | Dec 30, 2030 1554d | 40K | OTM | 0.1% | C$26K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
64,279,557 shares outstanding, plus 0 from warrants and 2,300,000 from options — a fully diluted 66,579,557 shares, or ~3.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2028-11-26.
Compare this book against every issuer →5 option grants covering 2,300,000 shares (~3.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.41 | Nov 26, 2028 790d | 1.2M | OTM | 1.9% | C$492K | Auto |
| option | $0.65 | Dec 30, 2028 824d | 750K | OTM | 1.2% | C$488K | Auto |
| option | $0.31 | Mar 24, 2029 908d | 250K | OTM | 0.4% | C$78K | Auto |
| option | $0.41 | Nov 26, 2030 1520d | 60K | OTM | 0.1% | C$25K | Auto |
| option | $0.65 | Dec 30, 2030 1554d | 40K | OTM | 0.1% | C$26K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
64,279,557 shares outstanding, plus 0 from warrants and 2,300,000 from options — a fully diluted 66,579,557 shares, or ~3.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
